Literature DB >> 33882692

NAD+ Repletion Reverses Heart Failure With Preserved Ejection Fraction.

Dan Tong1, Gabriele G Schiattarella1, Nan Jiang1, Francisco Altamirano1, Pamela A Szweda1, Abdallah Elnwasany1, Dong I Lee2, Heesoo Yoo1, David A Kass2, Luke I Szweda1, Sergio Lavandero1,3, Eric Verdin4, Thomas G Gillette1, Joseph A Hill1,5.   

Abstract

[Figure: see text].

Entities:  

Keywords:  NAD; acetylation; cardiomyopathy; heart failure; mitochondria

Mesh：

Substances：

Year:  2021        PMID： 33882692      PMCID： PMC8159891          DOI： 10.1161/CIRCRESAHA.120.317046

Source DB:  PubMed          Journal:  Circ Res        ISSN： 0009-7330            Impact factor:   23.213


  39 in total

1.  Disruption of Acetyl-Lysine Turnover in Muscle Mitochondria Promotes Insulin Resistance and Redox Stress without Overt Respiratory Dysfunction.

Authors:  Ashley S Williams; Timothy R Koves; Michael T Davidson; Scott B Crown; Kelsey H Fisher-Wellman; Maria J Torres; James A Draper; Tara M Narowski; Dorothy H Slentz; Louise Lantier; David H Wasserman; Paul A Grimsrud; Deborah M Muoio
Journal:  Cell Metab       Date:  2019-12-05       Impact factor: 27.287

Review 2.  Epidemiology of heart failure with preserved ejection fraction.

Authors:  Shannon M Dunlay; Véronique L Roger; Margaret M Redfield
Journal:  Nat Rev Cardiol       Date:  2017-05-11       Impact factor: 32.419

3.  Female Sex Is Protective in a Preclinical Model of Heart Failure With Preserved Ejection Fraction.

Authors:  Dan Tong; Gabriele G Schiattarella; Nan Jiang; Herman I May; Sergio Lavandero; Thomas G Gillette; Joseph A Hill
Journal:  Circulation       Date:  2019-11-18       Impact factor: 29.690

4.  SIRT3 regulates mitochondrial fatty-acid oxidation by reversible enzyme deacetylation.

Authors:  Matthew D Hirschey; Tadahiro Shimazu; Eric Goetzman; Enxuan Jing; Bjoern Schwer; David B Lombard; Carrie A Grueter; Charles Harris; Sudha Biddinger; Olga R Ilkayeva; Robert D Stevens; Yu Li; Asish K Saha; Neil B Ruderman; James R Bain; Christopher B Newgard; Robert V Farese; Frederick W Alt; C Ronald Kahn; Eric Verdin
Journal:  Nature       Date:  2010-03-04       Impact factor: 49.962

5.  Rapid inhibition of pyruvate dehydrogenase: an initiating event in high dietary fat-induced loss of metabolic flexibility in the heart.

Authors:  Clair Crewe; Michael Kinter; Luke I Szweda
Journal:  PLoS One       Date:  2013-10-07       Impact factor: 3.240

6.  Nicotinamide mononucleotide, an intermediate of NAD+ synthesis, protects the heart from ischemia and reperfusion.

Authors:  Takanobu Yamamoto; Jaemin Byun; Peiyong Zhai; Yoshiyuki Ikeda; Shinichi Oka; Junichi Sadoshima
Journal:  PLoS One       Date:  2014-06-06       Impact factor: 3.240

7.  Mouse SIRT3 attenuates hypertrophy-related lipid accumulation in the heart through the deacetylation of LCAD.

Authors:  Tongshuai Chen; Junni Liu; Na Li; Shujian Wang; Hui Liu; Jingyuan Li; Yun Zhang; Peili Bu
Journal:  PLoS One       Date:  2015-03-06       Impact factor: 3.240

Review 8.  Acetylation of Mitochondrial Proteins in the Heart: The Role of SIRT3.

Authors:  Rebecca M Parodi-Rullán; Xavier R Chapa-Dubocq; Sabzali Javadov
Journal:  Front Physiol       Date:  2018-08-07       Impact factor: 4.566

9.  Remodeling of the Acetylproteome by SIRT3 Manipulation Fails to Affect Insulin Secretion or β Cell Metabolism in the Absence of Overnutrition.

Authors:  Brett S Peterson; Jonathan E Campbell; Olga Ilkayeva; Paul A Grimsrud; Matthew D Hirschey; Christopher B Newgard
Journal:  Cell Rep       Date:  2018-07-03       Impact factor: 9.423

Review 10.  Mitochondrion as a Target for Heart Failure Therapy- Role of Protein Lysine Acetylation.

Authors:  Chi Fung Lee; Rong Tian
Journal:  Circ J       Date:  2015-08-04       Impact factor: 2.993
View more
  25 in total

Review 1.  The CD38 glycohydrolase and the NAD sink: implications for pathological conditions.

Authors:  Julianna D Zeidler; Kelly A Hogan; Guillermo Agorrody; Thais R Peclat; Sonu Kashyap; Karina S Kanamori; Lilian Sales Gomez; Delaram Z Mazdeh; Gina M Warner; Katie L Thompson; Claudia C S Chini; Eduardo Nunes Chini
Journal:  Am J Physiol Cell Physiol       Date:  2022-02-09       Impact factor: 4.249

Review 2.  Regulation of NAD+ metabolism in aging and disease.

Authors:  Xiaogang Chu; Raghavan Pillai Raju
Journal:  Metabolism       Date:  2021-10-28       Impact factor: 8.694

Review 3.  Heart failure in diabetes.

Authors:  Stanislovas S Jankauskas; Urna Kansakar; Fahimeh Varzideh; Scott Wilson; Pasquale Mone; Angela Lombardi; Jessica Gambardella; Gaetano Santulli
Journal:  Metabolism       Date:  2021-10-08       Impact factor: 8.694

4.  Immunometabolic Mechanisms of Heart Failure with Preserved Ejection Fraction.

Authors:  Gabriele G Schiattarella; Pilar Alcaide; Gianluigi Condorelli; Thomas G Gillette; Stephane Heymans; Elizabeth A V Jones; Marinos Kallikourdis; Andrew Lichtman; Federica Marelli-Berg; Sanjiv Shah; Edward B Thorp; Joseph A Hill
Journal:  Nat Cardiovasc Res       Date:  2022-03-14

Review 5.  Heart Failure with Preserved Ejection Fraction: Pathogenesis, Diagnosis, Exercise, and Medical Therapies.

Authors:  Qingyi Zhan; Wenjing Peng; Siqi Wang; Juan Gao
Journal:  J Cardiovasc Transl Res       Date:  2022-09-28       Impact factor: 3.216

6.  Sexually dimorphic effects of SARM1 deletion on cardiac NAD+ metabolism and function.

Authors:  Hina Lateef Nizami; Keaton E Minor; Ying Ann Chiao; Christine M Light; Chi Fung Lee
Journal:  Am J Physiol Heart Circ Physiol       Date:  2022-09-02       Impact factor: 5.125

7.  p53-Dependent Mitochondrial Compensation in Heart Failure With Preserved Ejection Fraction.

Authors:  Xiaonan Chen; Hao Lin; Weiyao Xiong; Jianan Pan; Shuying Huang; Shan Xu; Shufang He; Ming Lei; Alex Chia Yu Chang; Huili Zhang
Journal:  J Am Heart Assoc       Date:  2022-06-03       Impact factor: 6.106

8.  Sex differences in heart mitochondria regulate diastolic dysfunction.

Authors:  Yang Cao; Laurent Vergnes; Yu-Chen Wang; Calvin Pan; Karthickeyan Chella Krishnan; Timothy M Moore; Manuel Rosa-Garrido; Todd H Kimball; Zhiqiang Zhou; Sarada Charugundla; Christoph D Rau; Marcus M Seldin; Jessica Wang; Yibin Wang; Thomas M Vondriska; Karen Reue; Aldons J Lusis
Journal:  Nat Commun       Date:  2022-07-04       Impact factor: 17.694

9.  NAD Repletion Therapy: A Silver Bullet for HFpEF?

Authors:  Fadi G Akar; Lawrence H Young
Journal:  Circ Res       Date:  2021-05-27       Impact factor: 23.213

10.  NAD+ metabolism and cardiometabolic health: the human evidence.

Authors:  Mahmoud Abdellatif; Joseph A Baur
Journal:  Cardiovasc Res       Date:  2021-07-27       Impact factor: 13.081
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.